Bangkok Lab and Cosmetic PCLBKK:BLC 64 Return-on-Tangible-Equity is 6.98% as of Mar. 2026, which is 56% below its 10-year median of 15.86. GuruFocus rates BKK:BLC with a GF Score™ of 64/100 and a GF Value™ of ฿5.13 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 1,878 Consumer Packaged Goods companies, Bangkok Lab and Cosmetic PCL ranks better than 52.93% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Bangkok Lab and Cosmetic PCL's annualized net income for the quarter that ended in Mar. 2026 was ฿115 Mil. Bangkok Lab and Cosmetic PCL's average shareholder tangible equity for the quarter that ended in Mar. 2026 was ฿1,651 Mil. Therefore, Bangkok Lab and Cosmetic PCL's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 6.98%.
The historical rank and industry rank for Bangkok Lab and Cosmetic PCL's Return-on-Tangible-Equity or its related term are showing as below:
BKK:BLC'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 8.79 Med: 15.86 Max: 54.9
Current: 8.79
During the past 5 years, Bangkok Lab and Cosmetic PCL's highest Return-on-Tangible-Equity was 54.90%. The lowest was 8.79%. And the median was 15.86%.
BKK:BLC's Return-on-Tangible-Equity is ranked better than 52.93% of 1878
companies
in the Consumer Packaged Goods industry
Industry Median: 7.78
vs BKK:BLC: 8.79
Bangkok Lab and Cosmetic PCL (BKK:BLC) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Bangkok Lab and Cosmetic PCL Return-on-Tangible-Equity Related Terms
Bangkok Lab and Cosmetic PCL Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bangkok Lab and Cosmetic PCL Return-on-Tangible-Equity Chart
BKK:BLC vs PG, CL, KVUE: Return-on-Tangible-Equity Comparison
For the Household & Personal Products subindustry, Bangkok Lab and Cosmetic PCL's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bangkok Lab and Cosmetic PCL Return-on-Tangible-Equity vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Bangkok Lab and Cosmetic PCL's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Bangkok Lab and Cosmetic PCL's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 6.98% mean?
Bangkok Lab and Cosmetic PCL (BKK:BLC) has a Return-on-Tangible-Equity of 6.98% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Bangkok Lab and Cosmetic PCL and its competitors. This is 56% below median its historical median of 15.86. Over the past decade, Bangkok Lab and Cosmetic PCL's Return-on-Tangible-Equity has ranged from 8.79 to 54.90. According to the industry distribution chart, Bangkok Lab and Cosmetic PCL ranks #884 out of 1878 companies in the Consumer Packaged Goods industry, placing it in the top 47.1%.
Is Bangkok Lab and Cosmetic PCL's Return-on-Tangible-Equity too high?
Bangkok Lab and Cosmetic PCL's current Return-on-Tangible-Equity of 6.98% is 56% below median its 10-year median of 15.86. Over the past 10 years, this metric has ranged from a low of 8.79 to a high of 54.90. The Consumer Packaged Goods industry median Return-on-Tangible-Equity is 7.78. Bangkok Lab and Cosmetic PCL's value of 6.98% is 10.3% below this industry median. Based on the distribution chart, Bangkok Lab and Cosmetic PCL ranks #884 out of 1878 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Bangkok Lab and Cosmetic PCL has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bangkok Lab and Cosmetic PCL's Return-on-Tangible-Equity compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Bangkok Lab and Cosmetic PCL ranks #884 out of 1878 companies for Return-on-Tangible-Equity. This puts Bangkok Lab and Cosmetic PCL in the upper half of its industry. The industry median Return-on-Tangible-Equity is 7.78. Bangkok Lab and Cosmetic PCL's value of 6.98% is 10.3% below this benchmark. Historically, Bangkok Lab and Cosmetic PCL's own Return-on-Tangible-Equity has ranged from 8.79 to 54.90 over the past decade. While the company's 10-year median is 15.86 vs. the industry median of 7.78, Bangkok Lab and Cosmetic PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Consumer Packaged Goods company?
The median Return-on-Tangible-Equity among Consumer Packaged Goods companies is 7.78, based on 1,878 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bangkok Lab and Cosmetic PCL's current Return-on-Tangible-Equity of 6.98% is 10.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Bangkok Lab and Cosmetic PCL and its competitors. For the Consumer Packaged Goods industry, the median Return-on-Tangible-Equity is 7.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bangkok Lab and Cosmetic PCL's current Return-on-Tangible-Equity is 6.98%, which is 56% below median its own 10-year median of 15.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bangkok Lab and Cosmetic PCL stock overvalued right now?
Based on GuruFocus' analysis, Bangkok Lab and Cosmetic PCL (BKK:BLC) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿5.13, compared to a current price of ฿3.98 — trading 22.4% below its estimated fair value. The current Return-on-Tangible-Equity is 6.98%, which is 56% below median its 10-year median of 15.86 and 10.3% below the Consumer Packaged Goods industry median of 7.78. Bangkok Lab and Cosmetic PCL's overall GF Score™ is 64/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Bangkok Lab and Cosmetic PCL (BKK:BLC), the current Return-on-Tangible-Equity is 6.98% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bangkok Lab and Cosmetic PCL (BKK:BLC) Overvalued in 2026?
Based on GuruFocus' analysis, Bangkok Lab and Cosmetic PCL stock appears to be undervalued.
The current stock price of ฿3.98 is trading 22.4% below its estimated GF Value™ of ฿5.13.
GuruFocus considers Bangkok Lab and Cosmetic PCL to be Modestly Undervalued.
Key valuation signals for BKK:BLC:
Return-on-Tangible-Equity: 6.98% (56% below median its 10-year median of 15.86)
GF Value™: ฿5.13 vs. price of ฿3.98 (22.4% below fair value)
Industry Position: 10.3% below the Consumer Packaged Goods median (#884 of 1878)
No single metric tells the full story. See the BKK:BLC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bangkok Lab and Cosmetic PCL are one of Thailand's comprehensive healthcare solutions groups. The principal activities of the Group are the manufacturing and distributing of pharmaceuticals and medicinal chemical products for human and animal It operates in a single line of business, namely pharmaceuticals and medicinal chemical products, The Group derives revenue from sales of goods and rendering of services.
64GF Score
Get the complete analysis for BKK:BLC
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:BLC has been successfully added to your 
